Cardiff medical software company TrakCel will be increasing its headcount beyond 100 as it continues to expand its workforce to meet global demand for its product.
Having more than doubled its employee numbers during the financial year, the innovative software developer is set to recruit over 40 people in 2019.
The company’s recruitment drive comes off the back of 300% revenue growth in 2018.
To accommodate its growing team, the award-winning firm, which develops supply chain management software solutions for cell and gene therapy companies all over the world, has expanded into its third office in Cardiff city centre.
Forecasting for further growth this year, the firm is recruiting various roles at its Cardiff headquarters, including Customer Support, Technical Business Analysts and Software Developers.
With offices in the UK and North America, TrakCel has witnessed rapid growth in the US over the last year with over 80% of its business now deriving from there. Consequently, the company is also looking to recruit two Directors of Customer Delivery in the US to further enhance service levels to its growing North American client base.
To facilitate its recruitment drive, TrakCel has brought in Head of People and Talent, Joy Lewis-Middleton. HR specialist Joy brings a wealth of experience having held senior roles at Target Group and Capital Law.
She said:
“It’s an exciting time to be at TrakCel. We doubled in size last year and we are still growing. There are a number of roles we’re looking to fill across Software Development, Product Management, Testing, Business Analysis, Process Analysis and Project Management which we are confident of filling through local talent.
“We’re extremely passionate about what we do and what we do matters. That’s one of the main reasons people are attracted to working for us. Not only can they pursue their career with us, but they can do so knowing they’re helping bring truly life-changing products to the market through our innovative software.”
The growing field of personalised medicine is producing very promising treatments against a variety of cancers by utilising a patient’s own cells to target and fight back against cancer. TrakCel was developed in 2012 to trace and streamline the complex supply chains associated with these personalised treatments. It has since gone on to experience a huge demand for its innovative software.
CEO and co-founder Ravi Nalliah, who recently retained his place in the distinguished Medicine Maker Power List 2019, said:
“The last few years have been phenomenal in terms of business success and subsequent growth and we’re delighted to hit the 100-employee mark. We have huge aspirations to continue to grow our business globally and we need to increase our Wales-based workforce to facilitate this. It’s a pivotal time in our journey and we’re looking forward to welcoming more new people to the team over the course of the year.”
Established in 2012, TrakCel is an international technology company providing supply chain management software solutions to companies discovering, developing and commercialising cell and gene therapies and personalised medicine.
